Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

被引：14
|
作者：
Castilla, J. [1 ,2 ]
Martinez-Baz, I. [1 ,2 ]
Navascues, A. [3 ]
Fernandez-Alonso, M. [4 ]
Reina, G. [4 ]
Guevara, M. [1 ,2 ]
Chamorro, J. [3 ]
Ortega, M. T. [5 ]
Albeniz, E. [6 ]
Pozo, F. [7 ]
Ezpeleta, C. [3 ]
机构：
[1] Inst Salud Publ Navarra, Pamplona, Spain
[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res Ctr Epidemiol & Publ Hlth, Valencia, Spain
[3] Complejo Hosp Navarra, Pamplona, Spain
[4] Univ Navarra Clin, Pamplona, Spain
[5] Hosp Reina Sofia, Tudela, Spain
[6] Direcc Atenc Primaria, Navarre Hlth Serv, Pamplona, Spain
[7] WHO Natl Influenza Ctr Madrid, Ctr Nacl Microbiol, Inst Salud Carlos III, Majadahonda, Spain
来源：
EUROSURVEILLANCE | 2014年 / 19卷 / 06期
关键词：
D O I：
10.2807/1560-7917.ES2014.19.6.20700
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [41] Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
    Yang, Tianchi
    Tang, Ling
    Li, Pingping
    Li, Baojun
    Ye, Lixia
    Zhou, Jifang
    BMC GERIATRICS, 2024, 24 (01)
  • [42] Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season
    Pebody, R.
    Sile, B.
    Warburton, F.
    Sinnathamby, M.
    Tsang, C.
    Zhao, H.
    Ellis, J.
    Andrews, N.
    EUROSURVEILLANCE, 2017, 22 (04): : 18 - 22
  • [43] Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children A Case-Control Study
    Kelly, Heath
    Jacoby, Peter
    Dixon, Gabriela A.
    Carcione, Dale
    Williams, Simon
    Moore, Hannah C.
    Smith, David W.
    Keil, Anthony D.
    Van Buynder, Paul
    Richmond, Peter C.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (02) : 107 - 111
  • [44] Vaccine effectiveness against severe laboratory-confirmed influenza in children: Results of two consecutive seasons in Italy
    Menniti-Ippolito, Francesca
    Da Cas, Roberto
    Traversa, Giuseppe
    Santuccio, Carmela
    Felicetti, Patrizia
    Tartaglia, Loriana
    Trotta, Francesco
    Di Pietro, Pasquale
    Barabino, Paola
    Renna, Salvatore
    Riceputi, Laura
    Tovo, Pier-Angelo
    Gabiano, Clara
    Urbino, Antonio
    Baroero, Luca
    Le Serre, Daniele
    Virano, Silvia
    Perilongo, Giorgio
    Daverio, Marco
    Gnoato, Elisa
    Maretti, Michela
    Galeazzo, Beatrice
    Rubin, Giulia
    Scanferla, Stefania
    Da Dalt, Liviana
    Stefani, Chiara
    Zerbinati, Claudia
    Chiappini, Elena
    Sollai, Sara
    De Martino, Maurizio
    Mannelli, Francesco
    Becciani, Sabrina
    Giacalone, Martina
    Montano, Simona
    Remaschi, Giulia
    Stival, Alessia
    Furbetta, Mario
    Abate, Piera
    Leonardi, Ilaria
    Pirozzi, Nicola
    Raucci, Umberto
    Reale, Antonino
    Rossi, Rossella
    Russo, Cristina
    Mancinelli, Livia
    Manuela, Onori
    Carlo, Concato
    Mores, Nadia
    Romagnoli, Costantino
    Compagnone, Adele
    VACCINE, 2014, 32 (35) : 4466 - 4470
  • [45] Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan
    Suzuki, Motoi
    Katsurada, Naoko
    Minh Nhat Le
    Kaneko, Norihiro
    Yaegashi, Makito
    Hosokawa, Naoto
    Otsuka, Yoshihito
    Aoshima, Masahiro
    Yoshida, Lay Myint
    Morimoto, Konosuke
    VACCINE, 2018, 36 (21) : 2960 - 2967
  • [46] Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis
    Castilla, J.
    Moran, J.
    Martinez-Artola, V.
    Reina, G.
    Martinez-Baz, I.
    Garcia Cenoz, M.
    Alvarez, N.
    Irisarri, F.
    Arriazu, M.
    Elia, F.
    Salcedo, E.
    EUROSURVEILLANCE, 2011, 16 (07): : 4 - 9
  • [47] Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011
    Havers, Fiona
    Sokolow, Leslie
    Shay, David K.
    Farley, Monica M.
    Monroe, Maya
    Meek, James
    Kirley, Pam Daily
    Bennett, Nancy M.
    Morin, Craig
    Aragon, Deborah
    Thomas, Ann
    Schaffner, William
    Zansky, Shelley M.
    Baumbach, Joan
    Ferdinands, Jill
    Fry, Alicia M.
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (10) : 1304 - 1311
  • [48] Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
    Gao, Bu-Gang
    Huang, Ling-feng
    Xie, Ping
    OPEN LIFE SCIENCES, 2024, 19 (01):
  • [49] Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory Confirmed Influenza in 2014-2015 Season in Turkey: A Test-Negative Case Control Study
    Hekimoglu, Can Huseyin
    Emek, Mestan
    Avci, Emine
    Topal, Selmur
    Demiroz, Mustafa
    Ergor, Gul
    BALKAN MEDICAL JOURNAL, 2018, 35 (01) : 77 - 83
  • [50] Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States
    Chung, Jessie R.
    Flannery, Brendan
    Kim, Sara S.
    Gaglani, Manjusha
    Raiyani, Chandni
    Belongia, Edward A.
    McLean, Huong Q.
    Nowalk, Mary Patricia
    Zimmerman, Richard K.
    Jackson, Michael L.
    Jackson, Lisa A.
    Martin, Emily T.
    Monto, Arnold S.
    Patel, Manish
    VACCINE, 2021, 39 (25) : 3324 - 3328
12345